Singular Genomics Systems's market cap is currently $50.77M. The company's EPS TTM is $-34.92; its P/E ratio is ―; Singular Genomics Systems is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-8.10. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 2.91M	$ 765.00K	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -558.00K	$ -24.00K	$ -1.13M	$ -639.00K	$ -350.00K
Operating Income	$ -102.80M	$ -93.49M	$ -61.28M	$ -27.53M	$ -12.77M
EBITDA	$ -86.50M	$ -84.08M	$ -60.55M	$ -26.39M	$ -11.96M
Net Income	$ -94.82M	$ -88.27M	$ -98.89M	$ -28.66M	$ -12.34M
Balance Sheet
Cash & Short-Term Investments	$ 173.94M	$ 244.58M	$ 339.22M	$ 26.92M	$ 46.20M
Total Assets	$ 265.47M	$ 327.98M	$ 355.65M	$ 30.50M	$ 48.17M
Total Debt	$ 75.29M	$ 58.84M	$ 9.90M	$ 9.39M	$ 2.40M
Net Debt	$ 59.05M	$ -15.42M	$ -191.15M	$ -2.29M	$ -3.10M
Total Liabilities	$ 86.46M	$ 67.65M	$ 19.48M	$ 82.06M	$ 72.90M
Stockholders' Equity	$ 179.01M	$ 260.32M	$ 336.17M	$ -51.55M	$ -24.73M
Cash Flow
Free Cash Flow	$ -74.62M	$ -93.12M	$ -56.56M	$ -26.25M	$ -12.20M
Operating Cash Flow	$ -73.65M	$ -87.09M	$ -51.70M	$ -24.87M	$ -11.40M
Investing Cash Flow	$ 13.81M	$ -39.57M	$ -130.86M	$ 24.00M	$ -31.50M
Financing Cash Flow	$ 696.00K	$ 901.00K	$ 372.13M	$ 7.51M	$ 47.30M

Currency in USD

Singular Genomics Systems Earnings and Revenue History

Income Statement >

Singular Genomics Systems Debt to Assets

Balance Sheet >

Singular Genomics Systems Cash Flow

Cash Flow >

Singular Genomics Systems Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing